27687-14-5

Basic information

• Product Name: BOC-TRANEXAMIC ACID
• Synonyms: BOC-TRANS-4-(AMINOMETHYL)CYCLOHEXANE-1-CARBOXYLIC ACID;BOC-TRANEXAMIC ACID;RARECHEM EM WB 0226;TRANS-4-(TERT-BUTOXYCARBONYLAMINOMETHYL)CYCLOHEXANECARBOXYLIC ACID;TRANS-4-N-BOC-AMINOMETHYL-CYCLOHEXANECARBOXYLIC ACID;Boc-(4-aminomethyl)cyclohexane carboxylic acid;trans-4-(Boc-aminomethyl)cyclohexanecarboxylic Acid;Cyclohexanecarboxylic acid, 4-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-, trans- CAS_EXAMPLE
• CAS NO: 27687-14-5
• Molecular Formula: C₁₃H₂₃NO₄
• Molecular Weight: 257.33
• Product Categories: Amino Acids
• Mol File: 27687-14-5.mol
• Article Data: 22

Chemical Properties

• Melting Point: 133.0 to 137.0 °C
• Boiling Point: 410 °C at 760 mmHg
• Flash Point: 201.8 °C
• Appearance: /
• Density: 1.096 g/cm³
• Storage Temp.: Sealed in dry,Room Temperature
• Solubility: soluble in Methanol
• PKA: 4.85±0.10(Predicted)
• CAS DataBase Reference: BOC-TRANEXAMIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-TRANEXAMIC ACID(27687-14-5)
• EPA Substance Registry System: BOC-TRANEXAMIC ACID(27687-14-5)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 27687-14-5(Hazardous Substances Data)

Usage

Chemical Properties

White powder

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 1197-18-8 trans-4-aminomethyl-cyclohexyl-carboxylic acid 
• 108-20-3 di-isopropyl ether 
• 1197-17-7 4-aminomethyl-cyclohexanecarboxylic acid 
• 77-92-9 citric acid 
• 34619-03-9 tert-butyldicarbonate 

Downstream Products

• 100165-49-9 1-(isopropyloxycarbonyloxy)ethyl trans-4-aminomethylcyclohexanecarboxylate hydrochloride 
• 100165-52-4 phthalidyl trans-4-aminomethylcyclohexanecarboxylate hydrochloride 
• 87638-56-0 methylene bis dihydrochloride 
• 87589-46-6 C₂₀H₃₄N₂O₆*2ClH 
• 87589-45-5 (N,N-dimethylcarbamoyl)methylene bis dihydrochloride 
• 100227-65-4 C₂₂H₃₉N₃O₅*2ClH 
• 100165-55-7 C₂₁H₃₂N₂O₇*2ClH 
• 100165-48-8 1-(ethyloxycarbonyloxy)ethyl trans-4-aminomethylcyclohexanecarboxylate hydrochloride 
• 100165-50-2 4-Aminomethyl-cyclohexanecarboxylic acid 1-isobutyryloxy-ethyl ester; hydrochloride 
• 87589-22-8 pivaloyloxymethyl trans-4-aminomethylcyclohexanecarboxylate hydrochloride 
• 87589-32-0 4-Aminomethyl-cyclohexanecarboxylic acid isobutyryloxymethyl ester; hydrochloride 
• 87589-30-8 4-Aminomethyl-cyclohexanecarboxylic acid 1-acetoxy-ethyl ester; hydrochloride 
• 152438-03-4 H-Tra-CH₂Cl 
• 942119-88-2 trans-{4-[1-(4-bromo-thiophen-2-yl)-2-phenylethylcarbamoyl]-cyclohexylmethyl}-carbamic acid tert-butyl ester 

Relevant articles and documents

Discovery of Hydroxyamidine Derivatives as Highly Potent, Selective Indoleamine-2,3-dioxygenase 1 Inhibitors

In this study, a series of novel hydroxyamidine derivatives were identified as potent and selective IDO1 inhibitors by structure-based drug design. Among them, compounds 13-15 and 18 exhibited favorable enzymatic and cellular activities. Compound 18 showed improved bioavailability in mouse, rat, and dog (F% = 44%, 58.8%, 102.1%, respectively). With reasonable in vivo pharmacokinetic properties, compound 18 was further evaluated in a transgenic MC38 xenograft mouse model. The combination of compound 18 with PD-1 monoclonal antibody showed a synergistic antitumor effect. These data indicated that compound 18 as a potential cancer immunotherapy agent should warrant further investigation.

MOBILIZING CELLS EXPRESSING A TYPE 4 CXC CHEMOKINE RECEPTOR WITH 4-AMINO PYRIMIDINE COMPOUNDS

A method of mobilizing cells expressing the type 4 CXC chemokine receptor into the peripheral circulation by contacting them with an effective amount of a compound of formula (I) shown below (each variable in the formula being defined in the Specification

Halogenated sulfonamide derivatives

This invention is directed to halogenated sulfonamide derivatives which are ligands at the NPY Y5 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutic